News

To grasp the intricate pathology of many diseases today, scientists and researchers have achieved amazing advances in basic science. The ability of the human mind to think critically and come up with answers is unmatched, and some of that...

The Clinical Trial Information System went live on January 31, 2022, which began the one-year transition period for all clinical trial sponsors. Clinical trial sponsors are still free to decide whether to submit an initial clinical study application via...

Drugmakers' initial stock offerings, which had been a dependable tradition for years, mostly stopped in 2022. Fewer than two dozen biotech businesses priced initial public offerings (IPOs) last year, a 79% decrease from the total of the prior year...

The biotechnology sector had a decline in 2022 that went beyond just falling stock prices. Additionally, only 37 new drugs were approved by the FDA's primary review office last year, the lowest number since 2016. Yet there is cause for...

In the 70 pharmaceuticals featured in Clarivate Plc's Drugs to WatchTM 2023 study, comprising potential blockbuster drugs, the bulk were found to be personalised medicines. The report provides a predicted analysis of new medication launches or major indication launches in...

Metagenomics, the study of genetic material extracted directly from the stool microbiomes of people with PD and neurologically healthy control participants, was used by researchers at the University of Alabama at Birmingham in the US. The gut microbiome is engaged...

Innovative technology could help people with Type 1 diabetes who can't control their condition, and it will be made available to them. Additionally, the aid is going to be provided with little human involvement. With the technology being referred to...